Hernia Mesh Devices Market By Hernia Type (Inguinal Hernia, Incisional Hernia, Femoral Hernia, Others), By Mesh Type (Biologic Mesh, Synthetic Mesh), By Region, And Segment Forecasts, 2018 - 2025

Industry Insights

The global hernia mesh devices market size was valued at USD 176.9 million in 2016 and is projected to grow with CAGR of 1.3% over the forecast period. Hernia is a condition in which the lining of the abdomen bulges out into a small sac due to weakened abdominal muscles. Smoking, poor nutrition, genetic factors, and changes in lifestyle are some of the factors contributing to the elevated incidence of hernias. Persistent coughing due to smoking is one of the key causes of this condition, thus smokers are 4 times more susceptible to this disease. 

High incidence of hernia globally and improved patient outcomes by using meshes, which reduce operative and recovery time, are some of the factors contributing to growth. Furthermore, some of the advantages of using meshes in hernia repair are reduced chances of recurrence and alleviated pain, which are expected to accelerate the market growth.

According to HealthGrove, global annual mortality rate of hernia per 100,000 people is 0.5 and the annual years of healthy life lost is 14.7. According to FDA, more than a million hernia repair procedures are performed annually in the U.S. out of which, about 800,000 procedures are of the inguinal type.

Companies invest monetary and timely resources in research and development with the motive of constantly developing innovative products to meet patient centric needs and enable ease in procedures. For instance, in October 2014, Covidien plc launched ‘ReliaTack’, a minimally invasive device articulating fixation with a reloadable feature. The unique feature of this device enables an articulation of 65 degrees, which provides surgeons easy access to weak spots in the wall of the abdomen, helping attach the mesh more securely.

Hernia Type Insights

On the basis of nature of the target disease, the market is segmented by hernia type into inguinal, incisional, femoral, and others. Inguinal hernia dominated the market. Almost 80% of all hernias are inguinal in nature. Also, it is 10 times more common in men than women, which makes its repair expenditure mandatory. Other factors responsible for the dominance of this segment are patient feasibility due to tension-free procedures and more complications involved in the traditional operative techniques. Incidence of femoral hernia is low, but it is more common in older women owing to the wide shape of female pelvis 

Companies are actively involved in offering solutions for rare hernia cases. In 2010, PROCEED Ventral Patch (PVP) device was launched by Ethicon for the treatment of umbilical hernia. In 2016, GORE SYNECOR biomaterial, a product of W. L. Gore & Associates, was approved by FDA as a repair solution for ventral hernia.

Mesh Type Insights

On the basis of mesh type, the market is segmented into biologic and synthetic. Although the price of a biologic mesh is high compared to synthetic mesh, problems, such as inflammation and foreign body reaction, associated with synthetic mesh there is a shift of preference toward biologic mesh. Thus, biologic mesh is the faster growing segment. Technological advancements are also anticipated to propel the biologic mesh market during the forecast period. In March 2013, RTI Biologics, Inc. launched a new series of biological implants, Tutomesh and Tutopatch, both non-crosslinked collagen matrices. 

The type of mesh that is to be used in a surgery depends upon technical factors related to the complexity involved in the medical condition of a patient. The physician attending such a patient must have a thorough understanding of the product attributes and the patient condition while selecting a particular type of mesh for surgery.

Regional Insights

North America dominated the market in 2016 and is followed by Europe. The factors that are responsible for the large share are large population suffering from the disease, improved healthcare facilities, sedentary lifestyle practices, and high adoption of surgical meshes as a treatment option. 

Asia Pacific market is expected to show rapid growth owing to presence of large patient pool, dramatic increase in access and quality of healthcare, increase in awareness about target disorder management, and presence of a wide range of medical solutions. Almost 63% of all repair surgeries are performed in Asia Pacific. This provides manufacturers with lucrative opportunities, especially to those who offer affordable products.

Competitive Insights

The industry is highly competitive with many players operating in the market. Large multinational companies with a wide product portfolio coexist with companies that specialize in a particular product line. For instance, in January 2015, two major medical devices companies, Covidien plc. and Medtronic, Inc., merged under the name of Medtronic. This transaction is expected to boost the brand value and widen the product portfolio thus, giving competitive advantages to these players. Medtronic has a global presence and a wide range of surgical solutions, including a range of hernia products. 

New players have entered the market, for example, TELA Bio, which is a startup surgical reconstruction company that performs post-clinical study on patients to evaluate its products. Such activities help develop products and deliver better improvised offering, giving a competitive edge to existing players.

Players collaborate with each other to widen their network and offering. Atrium Medical was awarded three-year contract by the Premier, Inc. in 2010. The agreement gave Premier access to negotiated pricing for Atrium products, which will enable Premier to offer its member hospitals with simplified purchasing process and reasonable cost of products. Thus, patients who are a part of the Premier member hospitals get surgeries at a comparatively lower price. Such initiatives promote growth and help boost the market.

Some other key players are Ethicon, Inc.; C. R. Bard, Inc ; W. L. Gore and Associates, Inc.; Atrium Medical; LifeCell Corporation, and B. Braun Melsungen AG.

Report Scope

Segments covered in the report

This report forecasts revenue growth and provides an analysis on the industry trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the hernia mesh devices market on the basis of type, mesh type, and region:

• Hernia Type Outlook (Revenue, USD Million; 2014 - 2025)

  • Inguinal Hernia

  • Incisional Hernia

  • Femoral Hernia

  • Others

• Mesh Type Outlook (Revenue, USD Million; 2014 - 2025)

  • Biologic Mesh

  • Synthetic Mesh

• Regional Outlook (Revenue, USD Million; 2014 - 2025)

  • North America

    • U.S.

    • Canada

  • Europe

    • UK

    • Germany

    • France

  • Asia Pacific

    • Japan

    • China

    • India

  • Latin America

    • Brazil

    • Mexico

  • MEA

    • South Africa